INTERNATIONAL PATENT: WUHAN LIYUANHENG PHARMACEUTICAL TECHNOLOGY CO., LTD., 武汉利元亨药物技术有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION OF URSOLIC ACID AND MULTI-TARGET TYROSINE KINASE RECEPTOR INHIBITOR"

GENEVA, June 9 -- WUHAN LIYUANHENG PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room F, 19th Floor, International Building B, No. 1 Dandong Road, Jianghan DistrictWuhan, Hubei 430023), 武汉利元亨药物技术有限公司 (中国湖北省武汉市江汉区单洞路1号国际大厦B栋19楼F座) filed a patent application (PCT/CN2024/135055) for "PHARMACEUTICAL COMBINATION OF URSOLIC ACID AND MULTI-TARGET TYROSINE KINASE RECEPTOR INHIBITOR" on Nov 27, 2024. With publication no. WO/2025/113523, the details related to the patent application was published on Jun 05, 2025.

Nota...